The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

A single multipurpose gene-editing tool can correct several genetic conditions by restoring proteins that have been truncated ...

Now, scientists have published incredible findings from a Siberian mammoth they've named Yuka, revealing that they've found ...

People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.

Invivyd surged after Merck’s Cidara acquisition, but the read-through for IVVD is limited due to key differences. Learn why ...

Invivyd, Inc. advances VYD2311 as a Covid-19 vaccine alternative. Learn about upcoming trials and market opportunities. Click ...

The frozen remains of a juvenile woolly mammoth named Yuka preserved details about the animal’s last moments alive ...

For many people, COVID was not a short illness that faded with time. Months later, they still report fatigue, brain fog, ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

In other words, it’s a personalized cancer vaccine. Early tests of these vaccines are extremely promising. But the federal ...

Scientists have sequenced the oldest RNA from a 40,000-year-old mammoth named Yuka, unlocking genetic activity from its final ...